MTX, which is the anchor-drug for the treatment of RA, has been associated with lung injury
and in particular with MTX-related pneumonitis (M-pneu). Although the frequency of M-pneu …

Interstitial lung disease (ILD) has been recognized as a frequent manifestation associated
with a substantial morbidity and mortality burden in patients with autoimmune rheumatic …

Objective To evaluate rheumatoid arthritis (RA) disease activity and risk of RA‐associated
interstitial lung disease (RA‐ILD). Methods We investigated disease activity and risk of RA …

The mechanisms by which environmental exposures contribute to the pathogenesis of lung
fibrosis are unclear. Here, we demonstrate an increase in cadmium (Cd) and carbon black …

Objective To determine the association between novel lifestyle factors on risk of rheumatoid
arthritis (RA)-associated interstitial lung disease (ILD), define the threshold at which smoking …

Rheumatoid arthritis (RA) is an autoimmune disease characterised by chronic synovial
inlammation leading to joint destruction and bone erosions. Although the pathogenic …

Rheumatoid arthritis associated interstitial lung disease (RA-ILD) and idiopathic pulmonary
fibrosis (IPF) are distinct diseases; however, they share several clinical, radiographic and …

Objective. To summarise the epidemiology, risk and prognostic factors, and treatment
landscape of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Methods …

Background: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease. In this
disease, interstitial lung diseases (ILD) is associated with high risk of mortality. Rituximab, a …

Lung illness encountered in patients with rheumatic diseases bears clinical significance in
terms of increased morbidity and mortality as well as potential challenges placed on patient …